Rett Syndrome Research Trust News https://reverserett.org/rss-news.xml News brought to you by Rett Syndrome Research Trust Thu, 18 Jun 2026 21:06:15 -0500 Copyright Rett Syndrome Research Trust 60 A Single Shot That Rewrites the Code: What Intellia's CRISPR Breakthrough Means for Rett Families Thu, 07 May 2026 08:29:30 -0500 https://reverserett.org/news/articles/what-intellias-breakthrough-means-for-rett/ https://reverserett.org/news/articles/what-intellias-breakthrough-means-for-rett/ Herbivorous Dinosaur Seeking Connection Wed, 08 Apr 2026 11:26:33 -0500 https://reverserett.org/news/articles/herbivorous-dinosaur-seeking-connection/ https://reverserett.org/news/articles/herbivorous-dinosaur-seeking-connection/ 2025 Research Awards: $6.4 Million to Advance Genetic Medicines for Rett Wed, 01 Apr 2026 14:13:19 -0500 https://reverserett.org/news/articles/2025-research-awards/ https://reverserett.org/news/articles/2025-research-awards/ Coming Full Circle: Serendipity and Seizing the Day Mon, 30 Mar 2026 18:33:09 -0500 https://reverserett.org/news/articles/coming-full-circle/ https://reverserett.org/news/articles/coming-full-circle/ Rett Syndrome Research Trust Appoints Genevieve Laforet, MD, PhD as Chief Medical Officer, Strengthening Leadership in Genetic Medicine Development Mon, 30 Mar 2026 19:21:53 -0500 https://reverserett.org/news/press-releases/rsrt-appoints-genevieve-laforet-chief-medical-officer/ https://reverserett.org/news/press-releases/rsrt-appoints-genevieve-laforet-chief-medical-officer/ NGN-401 Embolden™ Trial is Fully Enrolled Tue, 24 Mar 2026 11:25:57 -0500 https://reverserett.org/news/articles/ngn-401-embolden-trial-is-fully-enrolled/ https://reverserett.org/news/articles/ngn-401-embolden-trial-is-fully-enrolled/ RNA Trans-splicing Comes of Age Fri, 13 Mar 2026 14:16:50 -0500 https://reverserett.org/news/articles/rna-trans-splicing-comes-of-age/ https://reverserett.org/news/articles/rna-trans-splicing-comes-of-age/ Rett Syndrome Research Trust Announces 2025 Research Awards to Advance Genetic Medicines Thu, 12 Feb 2026 16:18:13 -0600 https://reverserett.org/news/press-releases/rsrt-2025-research-awards-to-advance-genetic-medicine/ https://reverserett.org/news/press-releases/rsrt-2025-research-awards-to-advance-genetic-medicine/ University of Rochester Study: Auditory Processing in Rett Syndrome Thu, 22 Jan 2026 14:27:09 -0600 https://reverserett.org/news/articles/urmc-rettstudy/ https://reverserett.org/news/articles/urmc-rettstudy/ Taysha Program Update: January 2026 Tue, 06 Jan 2026 09:42:39 -0600 https://reverserett.org/news/articles/taysha-program-update-january-2026/ https://reverserett.org/news/articles/taysha-program-update-january-2026/ 2025 Rett Genetic Medicines Summit: Key Takeaways Tue, 18 Nov 2025 13:59:29 -0600 https://reverserett.org/news/articles/2025-rett-genetic-medicines-summit-highlights-next-steps/ https://reverserett.org/news/articles/2025-rett-genetic-medicines-summit-highlights-next-steps/ AI Meets Rett: RSRT Funds $1M Collaboration with Profluent to Advance Gene-editing with Artificial Intelligence Fri, 07 Nov 2025 12:00:21 -0600 https://reverserett.org/news/articles/profluent-rsrt-ai/ https://reverserett.org/news/articles/profluent-rsrt-ai/ Profluent and RSRT Partner to Target Rett Syndrome with AI-Designed Custom Genomic Medicines Fri, 14 Nov 2025 13:22:25 -0600 https://reverserett.org/news/press-releases/profluent-and-rsrt-partner-to-target-rett-syndrome-with-ai-designed-custom-genomic-medicines/ https://reverserett.org/news/press-releases/profluent-and-rsrt-partner-to-target-rett-syndrome-with-ai-designed-custom-genomic-medicines/ Neurogene Doses First Participant in Embolden™ Registrational Trial of NGN-401 for Rett Syndrome Thu, 06 Nov 2025 11:18:50 -0600 https://reverserett.org/news/articles/neurogene-doses-first-participant-in-embolden-trial-of-ngn-401-for-rett/ https://reverserett.org/news/articles/neurogene-doses-first-participant-in-embolden-trial-of-ngn-401-for-rett/ Taysha Receives FDA Breakthrough Therapy Designation for TSHA-102 Thu, 02 Oct 2025 10:28:50 -0500 https://reverserett.org/news/articles/taysha-receives-fda-breakthrough-therapy-designation-for-tsha-102/ https://reverserett.org/news/articles/taysha-receives-fda-breakthrough-therapy-designation-for-tsha-102/ Hey Universe! Science + Serendipity at RSRT Mon, 22 Sep 2025 19:30:57 -0500 https://reverserett.org/news/articles/hey-universe-science-serendipity-at-rsrt/ https://reverserett.org/news/articles/hey-universe-science-serendipity-at-rsrt/ RSRT Expands Internal Team to Speed the Advancement of Genetic Medicine Cures for Rett Syndrome Fri, 26 Sep 2025 21:11:25 -0500 https://reverserett.org/news/press-releases/rsrt-expands-internal-team-to-speed-genetic-medicine-cures/ https://reverserett.org/news/press-releases/rsrt-expands-internal-team-to-speed-genetic-medicine-cures/ Taysha Advances REVEAL Pivotal Trial for Rett Syndrome Tue, 12 Aug 2025 08:37:32 -0500 https://reverserett.org/news/articles/taysha-advances-reveal-pivotal-trial-for-rett-syndrome/ https://reverserett.org/news/articles/taysha-advances-reveal-pivotal-trial-for-rett-syndrome/ Monica Coenraads Makes Forbes 50 Over 50 List Fri, 01 Aug 2025 12:41:07 -0500 https://reverserett.org/news/articles/monica-honored-in-forbes-50-over-50/ https://reverserett.org/news/articles/monica-honored-in-forbes-50-over-50/ Neurogene Announces Trial Design for Embolden™ Study of NGN-401 Gene Therapy for Rett Syndrome Fri, 27 Jun 2025 18:38:49 -0500 https://reverserett.org/news/articles/neurogene-embolden-announce-june30-2025/ https://reverserett.org/news/articles/neurogene-embolden-announce-june30-2025/